Loading
Marseille neuro-oncologist who was lead author of AVAglio, the trial that showed adding bevacizumab to standard glioblastoma treatment delays progression but does not lengthen life.
Olivier Chinot leads neuro-oncology at Hôpital de la Timone in Marseille. He was first author of the 2014 New England Journal of Medicine report of AVAglio, the phase 3 trial in which bevacizumab added to radiotherapy and temozolomide improved progression-free survival but not overall survival in newly diagnosed glioblastoma, a result echoed by the parallel RTOG 0825 trial and which limited the drug's role in the disease.
| Title | Journal | Year |
|---|---|---|
| Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 1936 citations on Europe PMC. | New England Journal of Medicine | 2014 |
| EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 1583 citations on Europe PMC. | Nature Reviews Clinical Oncology | 2021 |
| Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook Europe PMC author record matched by affiliation (Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille); 933 citations on Europe PMC. | Cancer treatment reviews | 2020 |
One of the most cited papers Europe PMC returns for Olivier L. Chinot at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Olivier L. Chinot at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Olivier L. Chinot at Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Brain and spinal cord tumours (all types) and the tags brain, trialist.
Shares Glioma & glioblastoma and the tags brain, trialist.
Shares the tags brain, trialist.
Shares the tags brain, trialist.
Shares the tags brain, trialist.